{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:27:40Z","timestamp":1784723260319,"version":"3.55.0"},"reference-count":36,"publisher":"e-Century Publishing Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/dbfo6813","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T05:43:10Z","timestamp":1746510190000},"page":"1689-1704","source":"Crossref","is-referenced-by-count":7,"title":["Clinicopathological characteristics and prognostic outcomes of resectable hepatoid adenocarcinoma of the stomach: insights from a multicenter case-control study"],"prefix":"10.62347","volume":"15","author":[{"given":"Zhi-Yi","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-249.","journal-title":"CA Cancer J Clin"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/1097-0142(19850815)56:4<840::AID-CNCR2820560423>3.0.CO;2-E","article-title":"A case report","volume":"56","author":"Ishikura","year":"1985","unstructured":"Ishikura H, Fukasawa Y, Ogasawara K, Natori T, Tsukada Y and Aizawa M. An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report. Cancer 1985; 56: 840-848.","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/1097-0142(19930915)72:6<1827::AID-CNCR2820720606>3.0.CO;2-8","article-title":"A clinicopathologic and immunohistochemical analysis","volume":"72","author":"Nagai","year":"1993","unstructured":"Nagai E, Ueyama T, Yao T and Tsuneyoshi M. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis. Cancer 1993; 72: 1827-1835.","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/PAS.0b013e3181f0a873","article-title":"Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach","volume":"34","author":"Liu","year":"2010","unstructured":"Liu X, Cheng Y, Sheng W, Lu H, Xu X, Xu Y, Long Z, Zhu H and Wang Y. Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach. Am J Surg Pathol 2010; 34: 1465-1471.","journal-title":"Am J Surg Pathol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-230X-11-56","article-title":"Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer","volume":"11","author":"Baek","year":"2011","unstructured":"Baek SK, Han SW, Oh DY, Im SA, Kim TY and Bang YJ. Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer. BMC Gastroenterol 2011; 11: 56.","journal-title":"BMC Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/2319-4170.126860","article-title":"Clinicopathologial features of gastric hepatoid adenocarcinoma","volume":"38","author":"Lin","year":"2015","unstructured":"Lin CY, Yeh HC, Hsu CM, Lin WR and Chiu CT. Clinicopathologial features of gastric hepatoid adenocarcinoma. Biomed J 2015; 38: 65-69.","journal-title":"Biomed J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1443-9573.2007.00279.x","article-title":"Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma","volume":"8","author":"Gao","year":"2007","unstructured":"Gao YB, Zhang DF, Jin XL and Xiao JC. Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma. J Dig Dis 2007; 8: 23-28.","journal-title":"J Dig Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3109\/00365521.2015.1124286","article-title":"Hepatoid adenocarcinoma of the stomach--proper identification and treatment remain a challenge","volume":"51","author":"S&#xF8","year":"2016","unstructured":"S&#xF8;reide JA, Greve OJ, Gudlaugsson E and St&#xF8;rset S. Hepatoid adenocarcinoma of the stomach--proper identification and treatment remain a challenge. Scand J Gastroenterol 2016; 51: 646-653.","journal-title":"Scand J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1007\/s11596-018-1983-1","article-title":"Clinicopathological characteristics and prognosis of hepatoid adenocarcinoma of the stomach: evaluation of a pooled case series","volume":"38","author":"Zeng","year":"2018","unstructured":"Zeng XY, Yin YP, Xiao H, Zhang P, He J, Liu WZ, Gao JB, Shuai XM, Wang GB, Wu XL and Tao KX. Clinicopathological characteristics and prognosis of hepatoid adenocarcinoma of the stomach: evaluation of a pooled case series. Curr Med Sci 2018; 38: 1054-1061.","journal-title":"Curr Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"106975","DOI":"10.1016\/j.ejso.2023.07.001","article-title":"Long-term prognostic benefit of adjuvant chemotherapy for patients with hepatoid adenocarcinoma of the stomach after radical resection: a national multicenter study","volume":"49","author":"Huang","year":"2023","unstructured":"Huang ZN, Huang YQ, Hong QQ, Zhang P, Zhang ZZ, He L, Shang L, Wang LJ, Sun YF, Li ZX, Liu JJ, Ding FH, Lin ED, Fu YA, Lin SM, Lu J, Zheng CH, Huang CM and Li P. Long-term prognostic benefit of adjuvant chemotherapy for patients with hepatoid adenocarcinoma of the stomach after radical resection: a national multicenter study. Eur J Surg Oncol 2023; 49: 106975.","journal-title":"Eur J Surg Oncol"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Lin JX, Wang ZK, Hong QQ, Zhang P, Zhang ZZ, He L, Wang Q, Shang L, Wang LJ, Sun YF, Li ZX, Liu JJ, Ding FH, Lin ED, Fu YA, Lin SM, Xie JW, Li P, Zheng CH and Huang CM. Assessment of clinicopathological characteristics and development of an individualized prognostic model for patients with hepatoid adenocarcinoma of the stomach. JAMA Netw Open 2021; 4: e2128217.","DOI":"10.1001\/jamanetworkopen.2021.28217"},{"key":"ref11","unstructured":"Zhang JF, Shi SS, Shao YF and Zhang HZ. Clinicopathological and prognostic features of hepatoid adenocarcinoma of the stomach. Chin Med J (Engl) 2011; 124: 1470-1476."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1186\/s12885-020-07031-9","article-title":"The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis","volume":"20","author":"Zhou","year":"2020","unstructured":"Zhou K, Wang A, Ao S, Chen J, Ji K, He Q, Ji X, Wu X, Zhang J, Li Z, Bu Z and Ji J. The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis. BMC Cancer 2020; 20: 671.","journal-title":"BMC Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fmed.2017.00164","article-title":"Hepatoid adenocarcinoma of the stomach: a challenging diagnostic and therapeutic disease through a case report and review of the literature","volume":"4","author":"Fakhruddin","year":"2017","unstructured":"Fakhruddin N, Bahmad HF, Aridi T, Yammine Y, Mahfouz R, Boulos F, Awada A and Farhat F. Hepatoid adenocarcinoma of the stomach: a challenging diagnostic and therapeutic disease through a case report and review of the literature. Front Med (Lausanne) 2017; 4: 164.","journal-title":"Front Med (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Yang X, Wu Y, Wang A, Ma X, Zhou K, Ji K, Ji X, Zhang J, Wu X, Li Z and Bu Z. Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases. J Pathol Clin Res 2024; 10: e343.","DOI":"10.1002\/cjp2.343"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/JS9.0000000000001768","article-title":"Development of a staging system for hepatoid adenocarcinoma of the stomach based on multicenter data: a retrospective cohort study","volume":"111","author":"Huang","year":"2025","unstructured":"Huang YQ, Huang ZN, Hong QQ, Zhang P, Zhang ZZ, He L, Shang L, Wang LJ, Sun YF, Li ZX, Liu JJ, Ding FH, Lin ED, Fu YA, Lin SM, Chen QY, Zheng CH, Huang CM and Li P. Development of a staging system for hepatoid adenocarcinoma of the stomach based on multicenter data: a retrospective cohort study. Int J Surg 2025; 111: 718-727.","journal-title":"Int J Surg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1186\/s12885-017-3738-y","article-title":"Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer","volume":"17","author":"Feng","year":"2017","unstructured":"Feng F, Tian Y, Xu G, Liu Z, Liu S, Zheng G, Guo M, Lian X, Fan D and Zhang H. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. BMC Cancer 2017; 17: 737.","journal-title":"BMC Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12893-022-01667-z","article-title":"Comparison of CEA and CA19-9 as a predictive factor for recurrence after curative gastrectomy in gastric cancer","volume":"22","author":"Shibata","year":"2022","unstructured":"Shibata C, Nakano T, Yasumoto A, Mitamura A, Sawada K, Ogawa H, Miura T, Ise I, Takami K, Yamamoto K and Katayose Y. Comparison of CEA and CA19-9 as a predictive factor for recurrence after curative gastrectomy in gastric cancer. BMC Surg 2022; 22: 213.","journal-title":"BMC Surg"},{"key":"ref18","unstructured":"Liu J and Chen L. Current status and progress in gastric cancer with liver metastasis. Chin Med J (Engl) 2011; 124: 445-456."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00595-009-4142-2","article-title":"Gastrointestinal cancer metastasis and lymphatic advancement","volume":"40","author":"Kumagai","year":"2010","unstructured":"Kumagai K, Shimizu K, Yokoyama N, Aida S, Tanaka T and Yamagata K. Gastrointestinal cancer metastasis and lymphatic advancement. Surg Today 2010; 40: 301-306.","journal-title":"Surg Today"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.7150\/ijbs.71449","article-title":"Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach","volume":"18","author":"Jiang","year":"2022","unstructured":"Jiang J, Ding Y, Lu J, Chen Y, Chen Y, Zhao W, Chen W, Kong M, Li C, Teng X, Zhou Q, Xu N, Zhou D, Zhou Z, Wang H and Teng L. Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach. Int J Biol Sci 2022; 18: 5554-5574.","journal-title":"Int J Biol Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/sj.cr.7290121","article-title":"The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells","volume":"12","author":"MS","year":"2002","unstructured":"Li MS, Li PF, Yang FY, He SP, Du GG and Li G. The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells. Cell Res 2002; 12: 151-156.","journal-title":"Cell Res"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Qu BG, Bi WM, Qu BT, Qu T, Han XH, Wang H, Liu YX and Jia YG. PRISMA-compliant article: clinical characteristics and factors influencing prognosis of patients with hepatoid adenocarcinoma of the stomach in China. Medicine (Baltimore) 2016; 95: e3399.","DOI":"10.1097\/MD.0000000000003399"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12876-023-02773-9","article-title":"Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study","volume":"23","author":"Li","year":"2023","unstructured":"Li L, Yang X, Ji W, Zhu Q, Yang X, Niu J and Li W. Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study. BMC Gastroenterol 2023; 23: 142.","journal-title":"BMC Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.it.2022.04.001","article-title":"Immunomodulatory impact of &#x3B1;-fetoprotein","volume":"43","author":"PV","year":"2022","unstructured":"Munson PV, Adamik J and Butterfield LH. Immunomodulatory impact of &#x3B1;-fetoprotein. Trends Immunol 2022; 43: 438-448.","journal-title":"Trends Immunol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12880-023-01125-z","article-title":"Analysis of enhanced CT imaging signs and clinicopathological prognostic factors in hepatoid adenocarcinoma of stomach patients with radical surgery: a retrospective study","volume":"23","author":"Yan","year":"2023","unstructured":"Yan XY, Ju HY, Hou FJ, Li XT, Yang D, Tang L, Wang YK, Li ZW, Sun YS and Gao SY. Analysis of enhanced CT imaging signs and clinicopathological prognostic factors in hepatoid adenocarcinoma of stomach patients with radical surgery: a retrospective study. BMC Med Imaging 2023; 23: 167.","journal-title":"BMC Med Imaging"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Ling Q, Liu HL, Huang ST, Sun LF, Wu WW, Kudriashov V, Liu K, Yang K, Hu JK and Zhang WH. Clinicopathological features of hepatoid adenocarcinoma and non-hepatoid adenocarcinoma of the stomach: a systematic review and meta-analysis. Cancer Med 2024; 13: e70130.","DOI":"10.1002\/cam4.70130"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"789104","DOI":"10.3389\/fonc.2021.789104","article-title":"The value of perioperative chemotherapy for patients with hepatoid adenocarcinoma of the stomach undergoing radical gastrectomy","volume":"11","author":"Zhou","year":"2021","unstructured":"Zhou K, Wang A, Wei J, Ji K, Li Z, Ji X, Fu T, Jia Z, Wu X, Zhang J and Bu Z. The value of perioperative chemotherapy for patients with hepatoid adenocarcinoma of the stomach undergoing radical gastrectomy. Front Oncol 2021; 11: 789104.","journal-title":"Front Oncol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.21873\/anticanres.16975","article-title":"Safety and limitations of laparoscopic total gastrectomy for gastric cancer: a comparative analysis of short and long-term outcomes with open surgery","volume":"44","author":"Morino","year":"2024","unstructured":"Morino K, Yamamoto M, Shimoike N, Iwasaki Y, Yamanaka R, Nakanishi N, Matsusue R and Machimoto T. Safety and limitations of laparoscopic total gastrectomy for gastric cancer: a comparative analysis of short and long-term outcomes with open surgery. Anticancer Res 2024; 44: 1759-1766.","journal-title":"Anticancer Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.3390\/cancers13174455","article-title":"Ki-67 as a prognostic biomarker in invasive breast cancer","volume":"13","author":"Davey","year":"2021","unstructured":"Davey MG, Hynes SO, Kerin MJ, Miller N and Lowery AJ. Ki-67 as a prognostic biomarker in invasive breast cancer. Cancers (Basel) 2021; 13: 4455.","journal-title":"Cancers (Basel)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12022-023-09755-3","article-title":"Diagnostic, prognostic, and predictive role of Ki67 proliferative index in neuroendocrine and endocrine neoplasms: past, present, and future","volume":"34","author":"La Rosa","year":"2023","unstructured":"La Rosa S. Diagnostic, prognostic, and predictive role of Ki67 proliferative index in neuroendocrine and endocrine neoplasms: past, present, and future. Endocr Pathol 2023; 34: 79-97.","journal-title":"Endocr Pathol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41408-024-01162-z","article-title":"Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study","volume":"14","author":"Grover","year":"2024","unstructured":"Grover NS, Annunzio K, Watkins M, Torka P, Karmali R, Anampa-Guzman A, Oh TS, Reves H, Tavakkoli M, Hansinger E, Christian B, Thomas C, Barta SK, Geethakumari PR, Bartlett NL, Shouse G, Olszewski AJ and Epperla N. Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study. Blood Cancer J 2024; 14: 182.","journal-title":"Blood Cancer J"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s12029-024-01022-w","article-title":"The prognostic importance of Ki-67 in gastrointestinal carcinomas: a meta-analysis and multi-omics approach","volume":"55","author":"Razmi","year":"2024","unstructured":"Razmi M, Tajik F, Hashemi F, Yazdanpanah A, Hashemi-Niasari F and Divsalar A. The prognostic importance of Ki-67 in gastrointestinal carcinomas: a meta-analysis and multi-omics approach. J Gastrointest Cancer 2024; 55: 599-624.","journal-title":"J Gastrointest Cancer"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12876-020-01484-9","article-title":"Expression and significance of Her2 and Ki-67 in gastric adenocarcinoma without distant metastasis: a cohort study","volume":"20","author":"Wei","year":"2020","unstructured":"Wei Z, Huang L, Zhang X and Xu A. Expression and significance of Her2 and Ki-67 in gastric adenocarcinoma without distant metastasis: a cohort study. BMC Gastroenterol 2020; 20: 343.","journal-title":"BMC Gastroenterol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.7150\/jca.30074","article-title":"Ki-67\/MKI67 as a predictive biomarker for clinical outcome in gastric cancer patients: an updated meta-analysis and systematic review involving 53 studies and 7078 patients","volume":"10","author":"Xiong","year":"2019","unstructured":"Xiong DD, Zeng CM, Jiang L, Luo DZ and Chen G. Ki-67\/MKI67 as a predictive biomarker for clinical outcome in gastric cancer patients: an updated meta-analysis and systematic review involving 53 studies and 7078 patients. J Cancer 2019; 10: 5339-5354.","journal-title":"J Cancer"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4174\/astr.2019.96.1.27","article-title":"Ki-67 labeling index as a prognostic marker in advanced stomach cancer","volume":"96","author":"Seo","year":"2019","unstructured":"Seo SH, Kim KH, Oh SH, Choi Y, Ahn KJ, Lee JY, Lee SM, Park J and Kim WG. Ki-67 labeling index as a prognostic marker in advanced stomach cancer. Ann Surg Treat Res 2019; 96: 27-33.","journal-title":"Ann Surg Treat Res"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/4\/ajcr0161915.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:55:34Z","timestamp":1766022934000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/4\/ajcr0161915.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/dbfo6813","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}